600 patients66,869 observations120 daysLIVE

Patient P-01453

Synthetic patientNBL-101 · Day 115 · 75+ · M · baseline S19Open companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
24%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S19
  2. Day 16 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 16.

Primary contributors, last 14 days
  • GI instability+9
  • Inflammatory activity+8
  • Nutritional resilience-8
  • Treatment adherence+5

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients.

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 40
      • MicrobiomeAkkermansia low → thinner mucus layer
      • WearableSleep 5.7 h, below personal baseline
    • Inflammatory signalling 35
      • MicrobiomeBacteroides fragilis expansion
      • WearableHRV 34 ms, trending down
    • Butyrate / short-chain fatty acid production 25
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery 20
      • WearableShort sleep window
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 4 · butyrate capacity 71/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumLow
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    39 ms
    Sleep
    6.6 h
    Steps
    8,670
    Resting HR
    62 bpm
    Daily log: GI score 26, nutritional resilience 61, adherence 93.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0130233%S11SC-12no change94
    P-0173032%S1793
    P-0172332%S1293
    P-0132231%S0191
    P-0166235%S0291
    P-0152036%S0990
    P-0135431%S0390
    P-0146435%S0690
    P-0184035%S0390
    P-0176632%S05AD-05no change90
    P-0167133%S04SC-12improved90
    P-0142832%S1990